The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component
暂无分享,去创建一个
D. Weisenburger | J. Armitage | P. Bierman | J. Vose | M. Bast | C. Enke | F. Loberiza | Jamil Y. Abuzetun | R. Greg Bociek
[1] P. Gobbi,et al. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] V. Diehl,et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. , 2003, The New England journal of medicine.
[3] S. Horning,et al. Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] P. Vyas,et al. Pathology and genetics: Tumours of haematopoietic and lymphoid tissues , 2001 .
[5] L. Sobin,et al. World Health Organization classification of tumors , 2000, Cancer.
[6] D. Neuberg,et al. Assessment of the stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group pilot study E1492. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Armitage,et al. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. , 1998, The New England journal of medicine.
[8] S. Hancock,et al. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] K. Propert,et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. , 1992, The New England journal of medicine.
[10] M Tubiana,et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] F. Wilner,et al. Combination chemotherapy in the treatment of advanced Hodgkin's disease. , 1975, Michigan medicine.
[12] G. Bonadonna,et al. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP , 1975, Cancer.
[13] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[14] M. Peters. A Study of Survivals in Hodgkin's Disease Treated Radiologically , 1950 .
[15] John McGrath,et al. Hodgkin’s Disease , 1933, JAMA.
[16] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[17] Peters Mv,et al. A study of Hodgkin's disease treated by irradiation. , 1958 .
[18] M. Peters,et al. A study of Hodgkin's disease treated by irradiation. , 1958, The American journal of roentgenology, radium therapy, and nuclear medicine.
[19] D.,et al. Regression Models and Life-Tables , 2022 .